Acculi Labs, a supplier of deep-tech life growth solutions, has raised $1.5 million in a new investment round led by Sabi Holding India Ltd, valued at $25 million.
In 2020, PirE Ventures sponsored a seed fundraising round for the Bengaluru-based startup, which raised Rs 5 crore.
The company plans to use the new funding to speed the development of conscious AI insights systems, improve operational efficiency, and create infrastructure, according to a news statement.
Acculi Labs, which was co-founded by Rupam Das and Hari Prasath M in May 2017, intends to provide patients with home-based care. Lyfas, the company’s flagship device, offers early diagnosis and monitoring for asymptomatic patients, allowing them to approach their doctor early on.
It stated that with the introduction of Lyfas, it expanded its products from an initial cardiac health assessment system to a whole suite of health solutions. The platform claims that its mobile app can non-invasively capture psychophysiological biomarkers and provide a full health report in three minutes.
The business created Lyra, a cutting-edge, conscious AI that bridges the gap between carbon and silicon life forms. It has also launched the Lyfas Udyam program, which offers a micro-entrepreneurial circular economy for small firms to start and run by leveraging the ecosystem, processes, and financing.
Lyfas, a smartphone app that captures psychophysiological indicators non-invasively and delivers a thorough health assessment in three minutes, is one of Acculi Labs’ core offers. It also conducts a project called the Lyfas Udyam initiative, which creates an economy for small entrepreneurs to launch and operate their firms.
This comes at a time when the broader healthtech field has been gaining traction with investors for some time.
Read More: Click Here
